Qureight collaborates with AstraZeneca for AI lung disease research
Qureight and AstraZeneca have teamed up to help advance research into novel drugs for patients with complex lung diseases using AI models.
AI and Analytics
Qureight aims to reduce racial inequalities in lung disease treatment
Medical technology company Qureight is working with University Hospitals Birmingham to ensure its AI model for treating IPF reflects a diverse population.
AI and Analytics